These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

707 related items for PubMed ID: 9482363

  • 1. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
    Lipton RB, Stewart WF, Ryan RE, Saper J, Silberstein S, Sheftell F.
    Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
    [Abstract] [Full Text] [Related]

  • 2. Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.
    Silberstein SD, Armellino JJ, Hoffman HD, Battikha JP, Hamelsky SW, Stewart WF, Lipton RB.
    Clin Ther; 1999 Mar; 21(3):475-91. PubMed ID: 10321417
    [Abstract] [Full Text] [Related]

  • 3. Treatment of severe, disabling migraine attacks in an over-the-counter population of migraine sufferers: results from three randomized, placebo-controlled studies of the combination of acetaminophen, aspirin, and caffeine.
    Goldstein J, Hoffman HD, Armellino JJ, Battikha JP, Hamelsky SW, Couch J, Blumenthal H, Lipton RB.
    Cephalalgia; 1999 Sep; 19(7):684-91. PubMed ID: 10524663
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study.
    Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M.
    Arch Intern Med; 1999 Sep; 160(22):3486-92. PubMed ID: 11112243
    [Abstract] [Full Text] [Related]

  • 5. Results of a multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study comparing the fixed combination of acetaminophen, acetylsalicylic acid, and caffeine with ibuprofen for acute treatment of patients with severe migraine.
    Goldstein J, Hagen M, Gold M.
    Cephalalgia; 2014 Nov; 34(13):1070-8. PubMed ID: 24733408
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of nonprescription doses of ibuprofen for treating migraine headache. a randomized controlled trial.
    Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB.
    Headache; 2001 Nov; 41(7):665-79. PubMed ID: 11554954
    [Abstract] [Full Text] [Related]

  • 7. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study.
    Goldstein J, Silberstein SD, Saper JR, Ryan RE, Lipton RB.
    Headache; 2006 Mar; 46(3):444-53. PubMed ID: 16618262
    [Abstract] [Full Text] [Related]

  • 8. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
    Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM, Battikha JP, Hoffman H, Baggish J.
    Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
    [Abstract] [Full Text] [Related]

  • 9. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial.
    Silberstein SD, Freitag FG, Rozen TD, Kudrow DB, Hewitt DJ, Jordan DM, Fisher AC, Rosenthal NR, CAPSS-223 Investigators.
    Headache; 2005 Sep; 45(10):1317-27. PubMed ID: 16324164
    [Abstract] [Full Text] [Related]

  • 10. Use of a fixed combination of acetylsalicylic acid, acetaminophen and caffeine compared with acetaminophen alone in episodic tension-type headache: meta-analysis of four randomized, double-blind, placebo-controlled, crossover studies.
    Diener HC, Gold M, Hagen M.
    J Headache Pain; 2014 Nov 19; 15(1):76. PubMed ID: 25406671
    [Abstract] [Full Text] [Related]

  • 11. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
    Derosier F, Sheftell F, Silberstein S, Cady R, Ruoff G, Krishen A, Peykamian M.
    Headache; 2012 Apr 19; 52(4):530-43. PubMed ID: 22103635
    [Abstract] [Full Text] [Related]

  • 12. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
    Cady RK, McAllister PJ, Spierings EL, Messina J, Carothers J, Djupesland PG, Mahmoud RA.
    Headache; 2015 Jan 19; 55(1):88-100. PubMed ID: 25355310
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C, Gómez JP, Pradalier A, Titus i Albareda F, Joffroy A, Liaño H, Henry P, Lainez JM, Geraud G.
    Eur Neurol; 1999 Jan 19; 41(1):37-43. PubMed ID: 9885327
    [Abstract] [Full Text] [Related]

  • 14. The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: a post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
    Diener HC, Peil H, Aicher B.
    Cephalalgia; 2011 Oct 19; 31(14):1466-76. PubMed ID: 21908446
    [Abstract] [Full Text] [Related]

  • 15. Aspirin is efficacious for the treatment of acute migraine.
    Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN.
    Headache; 2005 Apr 19; 45(4):283-92. PubMed ID: 15836564
    [Abstract] [Full Text] [Related]

  • 16. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.
    Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B.
    Cephalalgia; 2005 Oct 19; 25(10):776-87. PubMed ID: 16162254
    [Abstract] [Full Text] [Related]

  • 17. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May 19; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 18. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
    Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B, Lipton RB.
    Cephalalgia; 2009 Feb 19; 29(2):188-93. PubMed ID: 18823361
    [Abstract] [Full Text] [Related]

  • 19. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.
    Arch Fam Med; 1998 Feb 19; 7(3):234-40. PubMed ID: 9596457
    [Abstract] [Full Text] [Related]

  • 20. Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study.
    MacGregor EA, Dowson A, Davies PT.
    Headache; 2002 Apr 19; 42(4):249-55. PubMed ID: 12010380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.